Please provide your email address to receive an email when new articles are posted on . Ovaprene, a monthly hormone-free contraceptive, blocked motile sperm in an early-phase study. There were no ...
Please provide your email address to receive an email when new articles are posted on . Levonorgestrel-releasing intrauterine system users vs. nonusers had an increased risk for breast cancer. Breast ...
Why should women in British Columbia, Manitoba, Prince Edward Island and the Yukon have access to free contraception while the rest of Canadians do not? Our new research, published in the British ...
While physicians say long-term reversible birth control can lead to better health outcomes for new mothers, hospitals often face financial barriers when rolling out these programs, according to The ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Venova Technologies, Inc., a women-led startup developing a novel long-acting, hormone-free and copper-free female birth control device, has been awarded a $2.23M ...
ROSWELL, Ga., Jan. 24, 2025 /PRNewswire/ -- Sebela Women's Health Inc., a part of Sebela Pharmaceuticals, today announced Contraception published positive results online from the Phase 3 study of the ...
Newly issued patent covers a new medical device and method to deliver and remove hydrogel within the body, including Plan A™’s sperm occlusion system. We have been thoughtfully innovating for several ...
The T-shaped intrauterine device releases levonorgestrel, a hormone that stops the womb lining from thickening and consequently prevents pregnancy. Women using Kyleena may also experience fewer days ...
In 1886, chemist W. J. Rendell manufactured the first birth control suppository. It contained a cocoa butter shell for suppositories that melted in the body to release the medication quinine, a drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results